EUR 23.9
(5.99%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 29.48 Million EUR | -40.2% |
2022 | 49.3 Million EUR | 833.35% |
2021 | 5.28 Million EUR | 6.06% |
2020 | 4.98 Million EUR | 0.0% |
2019 | - EUR | 0.0% |
2018 | - EUR | -100.0% |
2017 | 789.85 EUR | 0.0% |
2016 | - EUR | 0.0% |
2015 | - EUR | 0.0% |
2014 | - EUR | 0.0% |
2013 | - EUR | 0.0% |
2012 | - EUR | -100.0% |
2011 | 291 Thousand EUR | 0.0% |
2010 | - EUR | 0.0% |
2009 | - EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 10.86 Million EUR | 0.0% |
2023 Q2 | 8.8 Million EUR | 0.0% |
2023 FY | 29.48 Million EUR | -40.2% |
2023 Q4 | 29.48 Million EUR | 0.0% |
2022 FY | 49.3 Million EUR | 833.35% |
2022 Q2 | 9.03 Million EUR | 0.0% |
2022 Q4 | 49.3 Million EUR | 0.0% |
2021 FY | 5.28 Million EUR | 6.06% |
2021 Q2 | - EUR | 0.0% |
2021 Q4 | 4.4 Million EUR | 0.0% |
2020 Q2 | - EUR | 0.0% |
2020 FY | 4.98 Million EUR | 0.0% |
2020 Q4 | - EUR | 0.0% |
2019 FY | - EUR | 0.0% |
2019 Q2 | - EUR | 0.0% |
2019 Q4 | - EUR | 0.0% |
2018 FY | - EUR | -100.0% |
2018 Q4 | - EUR | 0.0% |
2018 Q2 | - EUR | 0.0% |
2017 Q2 | - EUR | 0.0% |
2017 FY | 789.85 EUR | 0.0% |
2017 Q4 | 789.85 EUR | 0.0% |
2016 FY | - EUR | 0.0% |
2016 Q2 | - EUR | 0.0% |
2016 Q4 | - EUR | 0.0% |
2015 Q4 | - EUR | 0.0% |
2015 Q2 | - EUR | 0.0% |
2015 FY | - EUR | 0.0% |
2014 Q2 | - EUR | 0.0% |
2014 Q4 | - EUR | 0.0% |
2014 FY | - EUR | 0.0% |
2013 FY | - EUR | 0.0% |
2013 Q4 | - EUR | 0.0% |
2013 Q2 | - EUR | 0.0% |
2012 FY | - EUR | -100.0% |
2012 Q4 | - EUR | 0.0% |
2012 Q2 | 1.57 Million EUR | 0.0% |
2011 FY | 291 Thousand EUR | 0.0% |
2010 FY | - EUR | 0.0% |
2009 FY | - EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
BioNTech SE | 219.1 Million EUR | 86.542% |
CureVac N.V. | 41.85 Million EUR | 29.558% |
Biotest Aktiengesellschaft | 689.8 Million EUR | 95.725% |
Biotest Aktiengesellschaft | 689.8 Million EUR | 95.725% |
BRAIN Biotech AG | 4.65 Million EUR | -532.883% |
Heidelberg Pharma AG | 5.83 Million EUR | -405.644% |
Medigene AG | 2.95 Million EUR | -899.525% |